C12Y 114/11004
Procollagen-lysine 5-dioxygenase , i.e. lysine-hydroxylase
Official title: Procollagen-lysine 5-dioxygenase (1.14.11.4), i.e. lysine-hydroxylase
C12Y114/11004 (Procollagen-lysine 5-dioxygenase , i.e. lysine-hydroxylase) appears on 16 US grants and 31 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 31
- Assignees
- 20
- Inventors
- 53
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 3 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin24 Mar 2026US 12,582,684 B2Krystal Biotech, Inc.
- Methods of delivering transgenes to the eye9 Jan 2024US 11,865,148 B2Krystal Biotech, Inc.
- Compositions and methods for the treatment of Netherton Syndrome9 May 2023US 11,642,384 B2Krystal Biotech, Inc.
- Recombinant yeast strains12 Jul 2022US 11,384,135 B2Modern Meadow, Inc.
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin30 Nov 2021US 11,185,564 B2Krystal Biotech, Inc.
- Production cells26 Jun 2025US 2025/0207168 A1Hoffmann-La Roche Inc.
- Improved expression of peptides20 Feb 2025US 2025/0059580 A1Gelita AG
- Mutant l-pipecolic acid hydroxylase and cis-5-hydroxy-l-pipecolic acid production method utilizing same8 Feb 2024US 2024/0043887 A1Api Corporation
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin28 Dec 2023US 2023/0414686 A1Krystal Biotech, Inc.
- Compositions and methods for treatment of netherton syndrome13 Jul 2023US 2023/0218691 A1Krystal Biotech, Inc.
Most cited
By later US patents
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin26US 9,877,990 B2Krystal Biotech, Inc. · 2018
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin15US 10,155,016 B2Krystal Biotech, Inc. · 2018
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin15US 10,441,614 B2Krystal Biotech, Inc. · 2019
- Compositions and methods for the treatment of wounds, disorders, and diseases of the skin11US 11,185,564 B2Krystal Biotech, Inc. · 2021
- Collagen producing plants and methods of generating and using same2US 8,455,717 B2CollPlant Ltd. · 2013